Free Trial

Essex Investment Management Co. LLC Has $2.74 Million Stake in Stereotaxis Inc. (NYSEAMERICAN:STXS)

Stereotaxis logo with Medical background

Key Points

  • Essex Investment Management Co. LLC increased its stake in Stereotaxis Inc. by 28.3%, acquiring an additional 343,130 shares, bringing its total holdings to approximately 1.56 million shares valued at $2.74 million.
  • Other institutional investors, like Legato Capital Management and Cherry Creek Investment Advisors, also boosted their positions, collectively owning around 45.35% of Stereotaxis stock.
  • Stereotaxis Inc. opened at $2.59 with a market cap of $222.74 million, experiencing a 52-week range between $1.54 and $2.72.
  • Need Better Tools to Track Stereotaxis? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Essex Investment Management Co. LLC raised its position in Stereotaxis Inc. (NYSEAMERICAN:STXS - Free Report) by 28.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,556,094 shares of the company's stock after purchasing an additional 343,130 shares during the period. Essex Investment Management Co. LLC owned approximately 1.84% of Stereotaxis worth $2,739,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the company. Legato Capital Management LLC increased its stake in Stereotaxis by 28.1% in the first quarter. Legato Capital Management LLC now owns 461,427 shares of the company's stock valued at $812,000 after purchasing an additional 101,136 shares in the last quarter. Cherry Creek Investment Advisors Inc. increased its stake in Stereotaxis by 16.6% in the first quarter. Cherry Creek Investment Advisors Inc. now owns 40,866 shares of the company's stock valued at $72,000 after purchasing an additional 5,825 shares in the last quarter. State of Wyoming increased its stake in Stereotaxis by 14.8% in the fourth quarter. State of Wyoming now owns 536,698 shares of the company's stock valued at $1,224,000 after purchasing an additional 69,259 shares in the last quarter. ProShare Advisors LLC increased its stake in Stereotaxis by 53.6% in the fourth quarter. ProShare Advisors LLC now owns 15,913 shares of the company's stock valued at $36,000 after purchasing an additional 5,556 shares in the last quarter. Finally, Lagoda Investment Management L.P. increased its position in shares of Stereotaxis by 7.7% during the fourth quarter. Lagoda Investment Management L.P. now owns 4,126,135 shares of the company's stock worth $9,408,000 after acquiring an additional 295,700 shares in the last quarter. Institutional investors own 45.35% of the company's stock.

Stereotaxis Trading Down 2.4%

Shares of STXS stock traded down $0.06 during trading hours on Friday, hitting $2.22. 347,234 shares of the company were exchanged, compared to its average volume of 437,649. The business has a 50 day moving average of $2.23 and a two-hundred day moving average of $2.13. Stereotaxis Inc. has a 52 week low of $1.54 and a 52 week high of $2.72. The company has a market capitalization of $190.49 million, a PE ratio of -7.14 and a beta of 1.44.

Stereotaxis Company Profile

(Free Report)

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.

Further Reading

Institutional Ownership by Quarter for Stereotaxis (NYSEAMERICAN:STXS)

Should You Invest $1,000 in Stereotaxis Right Now?

Before you consider Stereotaxis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stereotaxis wasn't on the list.

While Stereotaxis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines